Faculty Opinions recommendation of Acetylcysteine for the prevention of renal outcomes in patients with diabetes mellitus undergoing coronary and peripheral vascular angiography: a substudy of the acetylcysteine for contrast-induced nephropathy trial.

Author(s):  
Ashita Tolwani ◽  
Keith Wille
2013 ◽  
Vol 6 (2) ◽  
pp. 139-145 ◽  
Author(s):  
Otavio Berwanger ◽  
Alexandre Biasi Cavalcanti ◽  
Amanda M.G. Sousa ◽  
Anna Buehler ◽  
Helio José Castello-Júnior ◽  
...  

1988 ◽  
Vol 18 (4) ◽  
pp. 399-404 ◽  
Author(s):  
M. A. BARRADAS ◽  
D. S. GILL ◽  
V. A. FONSECA ◽  
D. P. MIKHAILIDIS ◽  
P. DANDONA

2012 ◽  
Vol 18 (3) ◽  
pp. 222-227
Author(s):  
YU. F. Salakhova ◽  
D. V. Duplyakov ◽  
E. R. Perunova ◽  
S. E. Burnazyan ◽  
E. I. Bazhenova ◽  
...  

Objective. To study the incidence and risk factors of contrast-induced nephropathy (CIN) resulted from percutaneous coronary interventions in cardiology practice. Design and methods. Retrospective analysis of 100 history cases of patients aged 37-73 years (mean age 56,1 ± 6,0 years) was preformed. 0mnipac-350 was used as a contrast agent during angiography. Glomerular filtration rate (GFR) was assessed by Cockroft-Gault formula before and 48 hours after the intervention. The patients were divided into 2 groups depending on the type of intervention: the first group included the patients with planned intervention and the second — with urgent endovascular intervention. Results. In the first group 3,0 % (n = 2) patients developed CIN, and one case was registered (2,95 %) in the second group. It developed in patients with initial decrease of GFR, in patients with diabetes mellitus and with the combination of both factors.


2003 ◽  
pp. 375-382
Author(s):  
Allen D. Hamdan ◽  
Frank B. Pomposelli ◽  
Gary W. Gibbons ◽  
Frank W. LoGerfo

1989 ◽  
Vol 86 (6) ◽  
pp. 801-808 ◽  
Author(s):  
Lance R. Peterson ◽  
Leann M. Lissack ◽  
Kenneth Canter ◽  
Claudine E. Fasching ◽  
Connie Clabots ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document